Clinical Evaluation of the PROGENSA(Registered Trademark) Prostate Cancer Gene 3 (PCA3) Assay in Men With a Previous Negative Biopsy Result
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jennifer Reid, PhD
Gen-Probe, Incorporated
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Healthcare Partners Medical Group
Los Angeles, California, United States
- San Diego Clinical Trials
San Diego, California, United States
- South Florida Medical Research
Aventura, Florida, United States
- Specialists in Urology
Naples, Florida, United States
- Florida Urology Specialists
Sarasota, Florida, United States
- Metropolitan Urology, Psc
Jeffersonville, Indiana, United States
- Regional Urology Specialists, Llc
Shreveport, Louisiana, United States
- Accumed Research Associates
Garden City, New York, United States
- Tristate Urologic Services Psc Inc. Dba the Urology Group
Cincinnati, Ohio, United States
- Columbus Urology Research, Llc
Columbus, Ohio, United States
- Md Anderson Cancer Center
Houston, Texas, United States
- Urology San Antonio Research
San Antonio, Texas, United States
- Virginia Urology
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2009
- Primary completion
- 30 Apr 2010
- Completion
- 30 Apr 2010
- Last update posted
- 12 Nov 2012
- Registered enrollment
- 507
- Registry id
- NCT01024959
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.